Morphofunctional, Gene, Inflammation Molecules and Oxidative Stress Analysis in Kidney Tissue of COVID-19 Patients
Launched by INSTITUTO NACIONAL DE ENFERMEDADES RESPIRATORIAS · Jun 3, 2024
Trial Information
Current as of March 12, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
MALE
Eligibility criteria
- Inclusion Criteria:
- • Not having at least one creatinine measurement.
- • Family members will not accept to participate.
- Exclusion Criteria:
- • Specimens with sub-optimal quality for analysis.
About Instituto Nacional De Enfermedades Respiratorias
The Instituto Nacional de Enfermedades Respiratorias (INER) is a leading research institution dedicated to the study and treatment of respiratory diseases in Mexico. As a pivotal clinical trial sponsor, INER focuses on advancing knowledge and improving therapeutic strategies for conditions such as asthma, chronic obstructive pulmonary disease (COPD), and pulmonary infections. With a commitment to high standards of scientific rigor and ethical conduct, INER collaborates with healthcare professionals, academic institutions, and industry partners to facilitate innovative research and enhance patient care in the field of respiratory health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Mexico City, Ciudad De México, Mexico
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0
Related articles
